Video

Managing secondary glaucoma due to intravitreal steroids

Author(s):

OT Staff Reports
Conferences|GLAUCOMA 360

L. Jay Katz, MD, of the Wills Eye Hospital, Philadelphia, PA, discusses the highlights of his Glaucoma 360 presentation on secondary glaucoma due to intravitreal steroids, and what ophthalmologists can do to minimize the risk of severe visual impairment in patients.

See more Glaucoma 360 coverage

Related Videos
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Related Content
ARVO Foundation reveals 2025 Dr David L Epstein Award recipients
January 28th 2025

ARVO Foundation reveals 2025 Dr David L Epstein Award recipients

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma
January 9th 2025

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals
January 7th 2025

Prevent Blindness Ohio offers free glaucoma resources to patients and professionals

Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment
December 13th 2024

Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment

© 2025 MJH Life Sciences

All rights reserved.